James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 3,000 shares at $74.03 ($222K) on 2019-03-07, disclosed to the SEC on 2019-03-11.
Open-market sale of $222k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.95 | 600 | $44K | 19.8% |
| 2 | $74.03 | 2,200 | $163K | 73.5% |
| 3 | $74.77 | 200 | $15K | 6.7% |
| Total | $73.86 avg | 3,000 | $222K | 100% |
| Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-07-09 | $399K | — | Filing → |
| GHDX | SELL | 2019-06-10 | $61K | — | Filing → |